DFDS A/S
Investor news no. 12/2021 |
DFDS reports monthly ferry volumes for freight and passengers to provide additional insight into the development of volume trends in DFDS’ European route network.
DFDS ferry volumes | |||||||
February | LTM* | ||||||
Freight | 2020 | 2021 | Change | 2020-19 | 2021-20 | Change | |
Lane metres, '000 | 3,290 | 3,440 | 4.5% | 41,104 | 40,639 | -1.1% | |
Passenger | 2020 | 2021 | Change | 2020-19 | 2021-20 | Change | |
Passengers, '000 | 238 | 20 | -91.6% | 5,126 | 1,089 | -78.8% | |
*Last twelve months |
Ferry – freight: Total volumes in February 2021 were 4.5% above 2020. Net adjustments for structural route changes reduced growth by 0.6 ppt to 3.9%. Volumes for routes calling the UK were up 4%.
North Sea volumes were above 2020 driven by added capacity and continued stabilisation of trade between the UK and the EU, particularly for UK imports. Lower UK exports increased the number of empty trailers coming back to the EU. Volumes on the English Channel were likewise above 2020. Volumes on the new route between Ireland and France continued to be ahead of expectations. Baltic Sea volumes were above 2020 adjusted for the closure of the Paldiski-Hanko route. Mediterranean volumes were above 2020 in all main corridors.
Ferry – passenger: Total number of passengers in February 2021 was 92% below 2020. The decrease reflects a continued negative impact from travel restrictions related to Covid-19 on the two cruise ferry routes, of which Oslo-Frederikshavn-Copenhagen was suspended in February, and the Channel. In the Baltic Sea, passenger numbers were somewhat below 2020.
DFDS’ ferry routes enable trade and travel in and around Europe. Click on the link to see a map of the entire network.
The March volume report is expected to be published on 13 April 2021.
Contact
Torben Carlsen, CEO, +45 33 42 32 01
Karina Deacon, CFO, +45 33 42 33 42
Søren Brøndholt Nielsen, IR, +45 33 42 33 59
Nicole Seroff, Communications, +45 31 40 34 46
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Genmab A/S18.10.2025 12:00:34 CEST | Press release
Genmab Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer
F. Hoffmann-La Roche Ltd18.10.2025 07:00:00 CEST | Press release
Roche’s phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer
StoneX Group Inc.18.10.2025 01:12:36 CEST | Press release
StoneX Expands Wealth Management Offering for Latin American Clients
F. Hoffmann-La Roche Ltd17.10.2025 22:20:00 CEST | Press release
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Eavor Technologies Inc.17.10.2025 18:00:00 CEST | Press release
Mark Fitzgerald Appointed President and Chief Executive Officer of Eavor Technologies Inc.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom